Current Edition

Upcoming Events

Advertisement

news

GSK sets sights on brain diseases through Oxford partnership

Diseases of the brain and central nervous system have been notoriously challenging to treat, even for the world's largest and most well-resourced drug companies. But...
Continue Reading →
news

Adamas, Flexion sell for $825M combined as biotech’s dealmaking pace picks up

The two deals announced Monday are attempts by Supernus and Pacira to fold small, revenue-generating drugs into a larger portfolio and boost their prospects. Supernu...
Continue Reading →
news

Gene therapy developer gets chance at a comeback with Pfizer deal

Voyager's first generation of gene therapies for ALS, Parkinson's and Huntington's disease, all now discontinued, relied on a direct infusion into brain tissue, an in...
Continue Reading →